ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Lou Gutheil

There's Something Rotten in China

Aug 31 2015 @ 15:08
While Brits are enjoying a bank holiday, Chinese reporters have been getting arrested for causing investor anxiety by reporting “great losses” as, well,  “great losses.” Yet, today, Monday, 31 August, the Shanghai Composite Index closed the month down 12.5%. It was the third month in a row that the index has fallen. In fact, August […]
 

And Now for Something Completely Different

Aug 26 2015 @ 15:12
Thank you, Monty Python, for the title – one that is sorely needed at the moment. People need to think about something other than the market correction set off by concerns out of and about China. We can’t afford to all be in a dither. It has been exciting for the global economy to seem […]
 

Don't Panic!

Aug 21 2015 @ 15:06
“The wisest rule in investment is: When others are selling, buy. When others are buying, sell. Usually, of course, we do the opposite. When everyone else is buying, we assume they know something we don’t, so we buy. Then people start selling, panic sets in, and we sell too.” ~ Jonathan Sacks “Panic is … […]
 

What's Up With Coal? Investors Need to Know.

Aug 20 2015 @ 14:46
The biggest financial news of the week, up until Greek Prime Minister Alexis Tsipras announced his resignation, has, arguable been George Soros investing the equivalent of £1.43 million in Arch Coal (NYSE:ACI) and Peabody Energy (NYSE:BTU), two coal mining companies that have have been struggling, having lost 98% of their value over the past several years. […]
 

A Bad Day for Glencore and the FTSE

Aug 19 2015 @ 13:23
It might have been a better day for Glencore’s (LSE:GLEN) share price and the FTSE 100 if the former had not had to publish its Q2 and H2 operations and financial report. The mining giant’s share price dropped by 9.74% to close at 158.95, continuing a decline that began a year ago on 25 July […]
 

Zulily Shares Soar 50% on Takeover Bid

Aug 17 2015 @ 15:25
Zulily, inc. (NASDAQ:ZU) shares soared nearly 50% on the NASDAQ exchange today after a joint announcement today that it will be acquired by Liberty Interactive Corp. (NASDAQ:QVCA), the owner of the popular home shopping network, QVC, for a sum of $2.4 billion. Zulily is an online retailer based in in the United States. The company […]
 

Tesla - A Stock for Fearless Investors

Aug 14 2015 @ 10:57
Tesla Motors (NASDAQ:TSLA) takes a beating in the media on a continual basis, but I L♥VE this company. Elon Musk is a creative visionary who doesn’t just dream about what could be done. He gets it done. Getting it done requires more than vision and technical expertise. It also requires extraordinary business acumen. Musk has it […]
 

What if China Devalued Its Currency?

Aug 11 2015 @ 17:32
Have you ever wondered what would happen if China decided to devalue it’s currency? Well, you don’t have to wonder any longer. Today the country’s central bank devalued its Yuan by 1.9% against the U.S. dollar – the most in two decades, and investors around the world headed for their cardiologists. The move “was partly […]
 

Genel Loses Nearly 13% After H1 Earnings

Aug 06 2015 @ 14:06
The share price of Genel Energy plc (LSE.GENL) dropped nearly 13% today after release of its first half year earnings report for the period ending 30 June 2015, despite increased revenue and EBITDAX over the same period in 2014. H1 revenue increased by 3.7% from $192.1 million in 2014 to $199.3 million for the current […]
 

Baxalta Shares Up 13% on Shire Public Offer

Aug 04 2015 @ 10:34
Baxalta shares (NYSE:BXLT) shares have risen by more than 13% to 38.47 today following publication of a hostile takeover bid by Shire PLC (LSE:SHP). U.S.-based Baxalta is a $6 billion global biopharmaceutical leader, developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Baxalta’s broad and diverse pipeline...
 
  • Jump to a different page:
  • 1
  • 2
  • 3
  • 4
  • 5
  • ...
  • 81
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com